Bristol-Myers Squibb Company (BMY) · page 136 of 197
This is a classic 'preempt rebuttal' slide used by activist investors to undermine management's optimistic projections.
Activist deck · preempt_rebuttal · preempt_rebuttal · dense density
Slide locked Sign in to view
Slide schematic 6/7
callout 1/1 list 1/1 metric 0/1 paragraph 1/1 source-note 1/1 title 2/2
1 without position metric 1
metric · primary
Components 7
primary bullet primary paragraph source-note action-title headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1